Brooke Balliett

Brooke Balliett is the Founder, CEO, and Clinical Director at California Center for Psychedelic Therapy. Additionally, Brooke works as a Psilocybin Therapist and Clinical Mentor at COMPASS Pathways. At Lykos Therapeutics, formerly MAPS PBC, Brooke serves as Co-Primary Investigator & Lead Therapist for clinical trials studying MDMA-Assisted Therapy for PTSD. Brook also holds roles at Zendo Project, Hollygrove, Adriana Anaya, PsyD, Children's Hospital Los Angeles (CHLA), UNM Hospitals, and Abt Associates where she has gained experience in a variety of therapeutic and clinical research roles. Educationally, Brooke holds a Doctorate of Psychology in Clinical Psychology from The Chicago School, a Master of Arts in Mental Health Counseling from Southwestern College, and a Bachelor's degree in Developmental Psychology from Mills College.